Mind Medicine (STU:MMQ) COGS-to-Revenue : 0.00 (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Mind Medicine COGS-to-Revenue?

Mind Medicine's Cost of Goods Sold for the three months ended in Sep. 2024 was €0.00 Mil. Its Revenue for the three months ended in Sep. 2024 was €0.00 Mil.

Mind Medicine's COGS to Revenue for the three months ended in Sep. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Mind Medicine's Gross Margin % for the three months ended in Sep. 2024 was N/A%.

Mind Medicine COGS-to-Revenue Historical Data

The historical data trend for Mind Medicine's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mind Medicine COGS-to-Revenue Chart

Mind Medicine Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Mind Medicine Quarterly Data
	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Mind Medicine COGS-to-Revenue Calculation

Mind Medicine's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Mind Medicine's COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Mind Medicine (STU:MMQ) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Mind Medicine's Gross Margin % for the three months ended in Sep. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Mind Medicine COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mind Medicine's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Mind Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mind Medicine Inc (STU:MMQ) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

MNMD:USA

Address

One World Trade Center, Suite 8500, New York, NY, USA, 10007

Website

https://www.mindmed.co

Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.

Mind Medicine Headlines

No Headlines